Aignostics, a spin-off of Charité – Universitätsmedizin Berlin and alumnus of the Berlin Institute of Health Digital Health Accelerator Program, has been named to Newsweek’s inaugural ranking of the “World’s Best Digital Health Companies 2024.”
On 28 February 2024, the team from Charité BIH Innovation (CBI) - the joint technology transfer of Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) - was delighted to receive a visit from Prof. Heyo. K. Kroemer, Chairman of the Executive Board of Charité, Prof. Dr Joachim Spranger, Dean of Charité, Prof. Dr Christopher…
Twice a year, the start-up competition Gründungswettbewerb – Digitale Innovationen by the Federal Ministry for Economic Affairs and Climate Protection's (BMWK) honors the best ideas of innovative start-ups that are based on digital technologies. The award supports start-ups in the early stages and emphasizes their key role as drivers of innovation…
On May 31, 2023, the sixth annual Demo Day of the BIH Digital Health Accelerator Program took place, bringing together a diverse group of innovative minds in the heart of Berlin. The event, hosted by the Berlin Institute of Health at Charité (BIH), showcased seven exceptional teams of Charité/BIH clinicians and researchers presenting their digital…
During the Corona pandemic, half a million researchers from more than 170 different fields published articles about the virus or the COVID-19 disease. Many of them were not really virus-experts, even automobile researchers published about Corona. In the new episode of the BIH-podcast, John Ioannidis, famous meta-researcher from Stanford and Berlin,…
The Haas group develops and applies novel multimodal single-cell and spatially-resolved technologies to study the complex etiology of hematological cancers and their interaction with the immune system.
Hematopoiesis describes the process of blood formation and is sustained by the activity of hematopoietic stem and progenitor cells throughout our lifetime. While our understanding of stem cell biology continues to grow, it still remains challenging to study the in vivo activity of individual stem cells in humans.
We performed a systematic review of concepts and solutions for use cases such as digital contact tracing to inform the current discussions on an optimal balance between privacy protection and pandemic control.
COVID-19: models, risks, evidence, debates and decisions